10502711000001108: Dostinex 500microgram tablets (PI) (Dowelhurst Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\UK product\Virtual medicinal product\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\UK product\Virtual therapeutic moiety\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\UK product\Virtual therapeutic moiety\Cabergoline\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\UK product\Trade family\Dostinex\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing cabergoline\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing cabergoline\Cabergoline\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing cabergoline\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing cabergoline\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing cabergoline\Cabergoline\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing cabergoline\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing cabergoline\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing cabergoline\Cabergoline\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing cabergoline\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet\Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

35844701000001116 Dostinex 500microgram tablets (PI) (Dowelhurst Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
35844801000001113 Dostinex 500microgram tablets (PI) (Dowelhurst Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
39773601000001119 Dostinex 500microgram tablets (Dowelhurst Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel Import - supplier (qualifier value)	false	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel import	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Is a	Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Has active ingredient	Cabergoline	false	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Is a	Dostinex	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Has specific active ingredient	Cabergoline	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd) 8 tablet	Is pack of	False	Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Inferred relationship	Existential restriction modifier
Dostinex 500microgram tablets (PI) (Dowelhurst Ltd) 8 tablet	Has AMP	True	Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
35844701000001116	Dostinex 500microgram tablets (PI) (Dowelhurst Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
35844801000001113	Dostinex 500microgram tablets (PI) (Dowelhurst Ltd)	en	Synonym	Inactive	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
39773601000001119	Dostinex 500microgram tablets (Dowelhurst Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module